[Metabolic syndrome and insulin resistance in patients with chronic hepatitis C].
Ter Arkh
; 82(10): 51-6, 2010.
Article
em Ru
| MEDLINE
| ID: mdl-21341465
ABSTRACT
AIM:
To estimate the incidence and clinical value of metabolic syndrome, insulin resistance, and steatosis in patients with chronic hepatitis C (CHC) caused by its virus genotype 1. SUBJECTS ANDMETHODS:
One hundred and fourteen patients (67 men and 47 women; mean age 44.9 +/- 13.3 years) were examined.RESULTS:
There were high incidence rates of metabolic syndrome (47.2%) and insulin resistance (50%), in the genesis of which the host-virus interaction is discussed. There was an independent correlation of the insulin resistance and elevated leptin levels with abdominal obesity and hepatic steatosis; however, these indicators did not correlate with the stage of fibrosis. At the same time hepatic steatosis (found in 38% of the patients) and its degree correlated with the stage of fibrosis. Thirty-four of 66 (54.5%) patients receiving antiviral therapy achieved a stable virological response.CONCLUSION:
Obesity, hyperglycemia, and significant insulin resistance along with the stage of hepatic cirrhosis are independent cofactors that determine no treatment response.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Resistência à Insulina
/
Hepatite C Crônica
/
Síndrome Metabólica
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Ano de publicação:
2010
Tipo de documento:
Article